Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy-Reference-Cited by-同舟云学术

Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy

Author:

Zeng Chang¹^ORCID,Stroup Emily Kunce¹,Zhang Zhou²,Chiu Brian C.-H.³,Zhang Wei²⁴⁵

Affiliation:

1. Driskill Graduate Program in Life Sciences; Northwestern University Feinberg School of Medicine; Chicago IL 60611 USA

2. Department of Preventive Medicine; Northwestern University Feinberg School of Medicine; 680 N. Lake Shore Dr., Suite 1400 Chicago IL 60611 USA

3. Department of Public Health Sciences; University of Chicago; Chicago IL 60637 USA

4. The Robert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine; Chicago IL 60611 USA

5. Institute of Precision Medicine; Jining Medical University; Jining 272067 Shandong P. R. China

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

Reference91 articles.

1. Cancer statistics, 2018;Siegel;Cancer J Clin.,2018

3. The challenge of patient adherence;Martin;Ther Clin Risk Manag,2005

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献